Clinical Trials Browser

Withdrawn × Endometrial Neoplasms × Magnetic Resonance Spectroscopy × Clear all

NCT05483023 2025-10-14

18-fluorofuranylnorprogesterone (FFNP) PET/MRI as a Potential Biomarker of Response to Progesterone Therapy

Phase 2 Withdrawn

Endometrial Neoplasms